About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 329839, 8 pages
http://dx.doi.org/10.1155/2013/329839
Research Article

Stage-Stratified Analysis of Prognostic Significance of Bax-Interacting Factor-1 Expression in Resected Colorectal Cancer

1Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Uijeongbu 480-717, Republic of Korea
2Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea
3Department of Biomedical Science, The Catholic University of Korea College of Medicine, Seoul 137-701, Republic of Korea
4Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul 137-701, Republic of Korea

Received 30 April 2013; Revised 27 August 2013; Accepted 27 August 2013

Academic Editor: Raymond L. Konger

Copyright © 2013 Yoon Ho Ko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Pisani, D. M. Parkin, F. Bray, and J. Ferlay, “Estimates of the worldwide mortality from 25 cancers in 1990,” International Journal of Cancer, vol. 83, no. 1, pp. 18–29, 1999.
  2. J. J. Y. Sung, J. Y. W. Lau, K. L. Goh et al., “Increasing incidence of colorectal cancer in Asia: implications for screening,” Lancet Oncology, vol. 6, no. 11, pp. 871–876, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Weitz, M. Koch, J. Debus, T. Höhler, P. R. Galle, and M. W. Büchler, “Colorectal cancer,” Lancet, vol. 365, no. 9454, pp. 153–165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Hector and J. H. M. Prehn, “Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review,” Biochimica et Biophysica Acta, vol. 1795, no. 2, pp. 117–129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Cuddeback, H. Yamaguchi, K. Komatsu et al., “Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax,” Journal of Biological Chemistry, vol. 276, no. 23, pp. 20559–20565, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Pierrat, M. Simonen, M. Cueto, J. Mestan, P. Ferrigno, and J. Heim, “SH3GLB, a new endophilin-related protein family featuring an SH3 domain,” Genomics, vol. 71, no. 2, pp. 222–234, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Takahashi, M. Karbowski, H. Yamaguchi et al., “Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis,” Molecular and Cellular Biology, vol. 25, no. 21, pp. 9369–9382, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Takahashi, D. Coppola, N. Matsushita et al., “Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis,” Nature Cell Biology, vol. 9, no. 10, pp. 1142–1151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Takahashi, T. Hori, T. K. Cooper et al., “Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy,” Blood, vol. 121, no. 9, pp. 1622–1632, 2013.
  10. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, “Autophagy fights disease through cellular self-digestion,” Nature, vol. 451, no. 7182, pp. 1069–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Knuutila, Y. Aalto, K. Autio et al., “DNA copy number losses in human neoplasms,” American Journal of Pathology, vol. 155, no. 3, pp. 683–694, 1999. View at Scopus
  12. J. W. Lee, E. G. Jeong, Y. H. Soung et al., “Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas,” Pathology, vol. 38, no. 4, pp. 312–315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Coppola, C. Oliveri, Z. Sayegh et al., “Bax-interacting factor-1 expression in prostate cancer,” Clinical Genitourinary Cancer, vol. 6, no. 2, pp. 117–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Y. Kim, Y. L. Oh, K. M. Kim et al., “Decreased expression of Bax-interacting factor-1 (Bif-1) in invasive urinary bladder and gallbladder cancers,” Pathology, vol. 40, no. 6, pp. 553–557, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Coppola, J. Helm, M. Ghayouri, M. P. Malafa, and H.-G. Wang, “Down-regulation of bax-interacting factor 1 in human pancreatic ductal adenocarcinoma,” Pancreas, vol. 40, no. 3, pp. 433–437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Coppola, F. Khalil, S. A. Eschrich, D. Boulware, T. Yeatman, and H.-G. Wang, “Down-regulation of bax-interacting factor-1 in colorectal adenocarcinoma,” Cancer, vol. 113, no. 10, pp. 2665–2670, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Fan, Y. Miao, X. Shan et al., “Bif-1 is overexpressed in hepatocellular carcinoma and correlates with shortened patient survival,” Oncology Letters, vol. 3, no. 4, pp. 851–854, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. Kim, N. J. Yoo, and S. H. Lee, “Somatic mutation of pro-cell death Bif-1 gene is rare in common human cancers,” APMIS, vol. 116, no. 10, pp. 939–940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Knösel, S. Petersen, H. Schwabe et al., “Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases,” Virchows Archiv, vol. 440, no. 2, pp. 187–194, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Camps, G. Armengol, J. del Rey et al., “Genome-wide differences between microsatellite stable and unstable colorectal tumors,” Carcinogenesis, vol. 27, no. 3, pp. 419–428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Jansson and X.-F. Sun, “Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer,” Journal of Clinical Oncology, vol. 20, no. 3, pp. 811–816, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. V. R. Katkoori, C. Suarez-Cuervo, C. Shanmugam et al., “Bax expression is a candidate prognostic and predictive marker of colorectal cancer,” Journal of Gastrointestinal Oncology, vol. 1, no. 2, pp. 76–89, 2010.
  23. I. Sturm, C.-H. Köhne, G. Wolff et al., “Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases,” Journal of Clinical Oncology, vol. 17, no. 5, pp. 1364–1374, 1999. View at Scopus
  24. J. Ho, J.-W. Kong, L.-Y. Choong et al., “Novel breast cancer metastasis-associated proteins,” Journal of Proteome Research, vol. 8, no. 2, pp. 583–594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Marx, “Autophagy: is it cancer's friend or foe?” Science, vol. 312, no. 5777, pp. 1160–1161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. X. H. Liang, S. Jackson, M. Seaman et al., “Induction of autophagy and inhibition of tumorigenesis by beclin 1,” Nature, vol. 402, no. 6762, pp. 672–676, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Takahashi, C. L. Meyerkord, T. Hori et al., “Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy,” Autophagy, vol. 7, no. 1, pp. 61–73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Mathew, V. Karantza-Wadsworth, and E. White, “Assessing metabolic stress and autophagy status in epithelial tumors,” Methods in Enzymology, vol. 453, pp. 53–81, 2009. View at Publisher · View at Google Scholar · View at Scopus